HTA A MULTIDIMENSIONAL TOOL FOR HEALTHCARE MANAGERS

Introducing health technologies with a high financial impact requires continuous monitoring, especially in an economic crisis and shortage of healthcare personnel. Prioritizing the technologies to be evaluated and assessing whether the results match the guidelines appears necessary. The recent EU report 2021/2282 on HTA stipulated that the focus should be on drugs, especially cancer drugs, and ATM in the first three years. In addition, the European Cancer Plan calls for more efficient drug supply management. However, measuring and reporting adherence to guidelines is costly and is carried out minimally, and further research is needed to overcome this gap in oncology and innovative oncology drugs. This research aims to improve the methodological framework by providing a tool to monitor the level of adherence to recommendations that can determine whether the prescriptions made are appropriate. To pursue the research objectives, this work adopts the case study method and implements a Qlik Sense Hub data warehouse with the parameters to be monitored. The study made it possible to develop an original standard procurement procedure to measure the appropriateness of prescriptions, which can improve cost management and management of the supply of oncology drugs and innovative oncology drugs, strengthening the Health System.